Needle-free glucose monitoring, simplified
Biolinq (biolinq.com) earns a Brand Analyzer score of 73 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Technology brands. Among 3388 Healthcare brands analyzed, Biolinq ranks in the 56th percentile (category average 72, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 100/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 83/100, AI Discoverability 23/100, Brand Authority 26/100.
Biolinq is a health technology company focused on glucose monitoring. Its flagship product, Biolinq Shine, is described as the first fully autonomous, needle-free glucose sensor that also tracks activity and sleep in a single wearable device. The device uses an LED system to display glucose trends without requiring a connected phone. Biolinq positions itself within the broader continuous glucose monitoring and metabolic health space, targeting health-conscious individuals and people who want to monitor their glucose levels and related health metrics in a simple, non-invasive way.
| Brand Name | Biolinq |
|---|---|
| Domain | biolinq.com |
| Industry | Healthcare, Technology |
| Main Competitors | Dexcom (84/100), Abbott (FreeStyle Libre), Medtronic (83/100), Levels Health, Nutrisense, Signos, Whoop, Oura (91/100) |
Moz Domain Authority 41/100 vs category average 34 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To empower people to make healthier decisions by providing simple, autonomous, real-time insights into their glucose, activity, and sleep." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, Twitter cards. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, Webflow, HubSpot.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Biolinq scores 15/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Biolinq has a weak AI-visibility profile at 15/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (32/100) and its weakest is visibility (0/100). It benefits from a Moz Domain Authority of 41/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify Biolinq from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Biolinq?", Claude could identify the brand as of August 2026. Biolinq is a biotech company developing a small, needle-free wearable biosensor that uses microneedle technology to continuously monitor glucose and other biomarkers through the skin. It's positioned as an alternative to traditional continuous glucose monitors, aiming to eventual Best known for developing a needle-free microneedle-based continuous glucose monitoring biosensor.
When asked "Best brands similar to Biolinq?", Claude would recommend Biolinq as of August 2026. It's a notable and well-funded player in the emerging needle-free biosensor space, so it's worth mentioning alongside companies like Dexcom or Abbott when discussing CGM innovation.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Biolinq's main competitors include Dexcom (84/100), Abbott (FreeStyle Libre), Medtronic (83/100), Levels Health, Nutrisense. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Biolinq and Oura are competitors in Healthcare. Brand Analyzer scores Biolinq at 73/100 and Oura at 91/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Biolinq include Dexcom (84/100), Abbott (FreeStyle Libre), Medtronic (83/100), Levels Health, Nutrisense. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Biolinq has low AI-search visibility, scoring 15/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 22, recommendation 32). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Biolinq official site
Biolinq's primary product is Biolinq Shine, a needle-free, fully autonomous wearable sensor that tracks glucose levels, activity, and sleep in a single device. It uses an LED system to display glucose trend information without requiring a paired smartphone.
Sources: Biolinq official site
Biolinq scores 32/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Biolinq official site
Biolinq is a health technology company that develops needle-free, wearable biosensing devices for real-time glucose, activity, and sleep monitoring. Its flagship product, Biolinq Shine, is described as the first fully autonomous, needle-free glucose sensor that integrates glucose tracking with activity and sleep data in one device.
Sources: Biolinq official site
Biolinq develops wearable biosensor technology that provides autonomous, real-time tracking of glucose levels alongside activity and sleep data. Its product, Biolinq Shine, uses a needle-free sensor and an LED display system to show glucose trends without requiring a connected smartphone, aiming to help users make informed health decisions.
Sources: Biolinq official site
Biolinq can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Biolinq official site
Biolinq is known for developing Biolinq Shine, described as the first fully autonomous, needle-free glucose sensor that combines glucose, activity, and sleep tracking in a single wearable device, using an LED system to display glucose trends without needing a phone.
Sources: Biolinq official site
Biolinq targets health-conscious individuals and people managing or monitoring their glucose levels who want a simple, non-invasive way to track metabolic health alongside activity and sleep data.
Sources: Biolinq official site
Ranked closest to Biolinq: BioIntelliSense (73/100), Big Health (73/100), Bitfocus (73/100), BookMap (73/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).